This document summarizes the biological treatments for obsessive compulsive disorder (OCD) according to the DSM-5 criteria. It discusses the neurobiology of OCD including structural changes in the brain, functional studies showing increased activity in certain areas, and neurotransmitter imbalances. FDA approved medications for OCD like SSRIs and clomipramine are outlined. Augmentation strategies and treatments for resistant cases are provided. Other somatic therapies explored include repetitive transcranial magnetic stimulation, deep brain stimulation, electroconvulsive therapy, and vagus nerve stimulation. Neurosurgical procedures are discussed as last line treatments for severe, long-standing OCD.